A phase I trial of ganetespib in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breast cancer - Komal Jhaveri; Rui Wang; Eleonora Teplinsky; Sarat Chandarlapaty; David Solit; Karen Cadoo; James Speyer; Gabriella D’Andrea; Sylvia Adams; Sujata Patil; Sofia Haque; Tara O’Neill; et al. (Breast Cancer Research, 2017)